Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation (Q40868665)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2015
edit
Language Label Description Also known as
English
Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation
scientific article published on June 2015

    Statements

    Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation (English)
    Vincent Leroy
    Jérôme Dumortier
    Audrey Coilly
    Claire Fougerou-Leurent
    Sylvie Radenne
    Danielle Botta
    François Durand
    Christine Silvain
    Pascal Lebray
    Pauline Houssel-Debry
    Louis D'Alteroche
    Ventzislava Petrov-Sanchez
    Georges-Philippe Pageaux
    Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO23 Compassionate Use of Protease Inhibitors in Viral C in Liver Transplantation Study Group
    Alpha Diallo
    1 June 2015
    1993-2001.e1-2

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit